Indigo Biosciences Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Indigo Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014323
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Indigo Biosciences Inc (Indigo) is a provider of preclinical contract research services for pharmaceutical research and development, biotechnology sectors. The company’s products include assay kit platforms and formats, nuclear receptor, signaling pathway, and cell viability assay products, mitochondrial function products, and luciferase detection reagents. Its other products comprise assay and format plates, human liver receptors, human nucelar factro assay systems, human and rat pregnane X receptors, NFkB assay systems, and human estrogen related receptor gamma assay systems. Indigo also provides human AhR assay kits, mouse CAR assay kits, human ERRa assay kits, rat PPARa assay kits, ROR? assay kits, human mitochondrial RNA polymerase systems, and others. The company offers services such as screening, contract research, nuclear receptor reporter assays and panel services, custom assay development services, and others. Indigo is headquartered in State College, Pennsylvania, the US.

Indigo Biosciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Indigo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Indigo Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Indigo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Indigo Biosciences Inc, Medical Devices Deals, 2011 to YTD 2017 8
Indigo Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Indigo Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Indigo Biosciences Raises USD0.5 Million in Series B Financing 10
Indigo Biosciences Secures US$0.68 Million In Venture Financing 11
Private Equity 12
iNetworks Invests In Indigo Biosciences 12
Partnerships 13
Indigo Biosciences Enters into Distribution Agreement with upcyte technologies 13
Indigo Biosciences Inc – Key Competitors 14
Indigo Biosciences Inc – Key Employees 15
Indigo Biosciences Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Indigo Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts 2
Indigo Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Indigo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Indigo Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Indigo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Indigo Biosciences Inc, Medical Devices Deals, 2011 to YTD 2017 8
Indigo Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Indigo Biosciences Raises USD0.5 Million in Series B Financing 10
Indigo Biosciences Secures US$0.68 Million In Venture Financing 11
iNetworks Invests In Indigo Biosciences 12
Indigo Biosciences Enters into Distribution Agreement with upcyte technologies 13
Indigo Biosciences Inc, Key Competitors 14
Indigo Biosciences Inc, Key Employees 15

★海外企業調査レポート[Indigo Biosciences Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Boulevard Holdings, Inc.:企業の戦略・SWOT・財務分析
    Boulevard Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Boulevard Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Hague and London Oil PLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Hague and London Oil PLC (HALO), formerly Wessex Exploration plc, is an oil and gas exploration company that develops resource properties. The company acquires, explores, produces, and develops oil and gas resource properties across the UK. Its projects comprise assets in the Philippines, Gu …
  • Technopromexport:企業の戦略的SWOT分析
    Technopromexport - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • G4S Plc (GFS):企業の財務・戦略的SWOT分析
    G4S Plc (GFS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Huneed Technologies:企業の戦略・SWOT・財務分析
    Huneed Technologies - Strategy, SWOT and Corporate Finance Report Summary Huneed Technologies - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Compania Minera Autlan SAB de CV:企業の戦略・SWOT・財務情報
    Compania Minera Autlan SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Compania Minera Autlan SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Evine Live Inc.
    Evine Live Inc. - Strategy, SWOT and Corporate Finance Report Summary Evine Live Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • ULURU Inc (ULUR)-医療機器分野:企業M&A・提携分析
    Summary ULURU Inc (ULURU) is a developer and commercializer of wound care and muco-adhesive film products. The company’s products include Altrazeal and OraDisc. Its Altrazeal is a transforming powder dressing with Nanoflex technology for the management of exuding wounds. ULURU’s OraDisc is a polymer …
  • PizzaExpress Limited:企業の戦略・SWOT・財務情報
    PizzaExpress Limited - Strategy, SWOT and Corporate Finance Report Summary PizzaExpress Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Atlas Energy Group LLC:企業の戦略・SWOT・財務情報
    Atlas Energy Group LLC - Strategy, SWOT and Corporate Finance Report Summary Atlas Energy Group LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • DexCom Inc (DXCM):企業の製品パイプライン分析
    Summary Dexcom Inc (Dexcom) is a medical device company that designs, develops and commercializes continuous glucose monitoring (CGM) systems. The company’s major products include integrated CGM systems for adults and pediatric use, Dexcom G5 mobile CGM system, Dexcom G4 PLATINUM CGM system, associa …
  • Bolu Cimento Sanayii AS:企業の戦略・SWOT・財務情報
    Bolu Cimento Sanayii AS - Strategy, SWOT and Corporate Finance Report Summary Bolu Cimento Sanayii AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • EnBW Energie Baden-Wurttemberg AG:発電所・企業SWOT分析
    EnBW Energie Baden-Wurttemberg AG - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Buckeye Partners LP (BPL):石油・ガス:M&Aディール及び事業提携情報
    Summary Buckeye Partners LP (Buckeye) is a provider of midstream logistic solutions. It owns and operates a diversified network of integrated assets for the transportation, storage, processing and marketing of liquid petroleum products. The company transports liquid petroleum products, including gas …
  • OCI Co Ltd (010060):電力:M&Aディール及び事業提携情報
    Summary OCI Co Ltd (OCI) is a green energy and chemical company. It manufactures and sells a wide range of inorganic chemicals, coal and petrochemicals, and fine chemicals. The company’s product portfolio includes toluene di-isocyanate (TDI), hydrogen peroxide, carbon black, pitch, sodium percarbona …
  • Nexira:企業の戦略・SWOT・財務情報
    Nexira - Strategy, SWOT and Corporate Finance Report Summary Nexira - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • BioVendor – Laboratorni Medicina as:製薬・医療:M&Aディール及び事業提携情報
    Summary BioVendor - Laboratorni Medicina as (BioVendor) is a developer and manufacturer of immunoassays, recombinant protiens, antibodies and endotoxin-removal products. The company provides products such as immunoassays, proteins, antibodies, endotoxin removal products, endotoxin detection products …
  • Toyo Tire & Rubber Co Ltd (5105):企業の財務・戦略的SWOT分析
    Toyo Tire & Rubber Co Ltd (5105) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Genting Malaysia Berhad:企業の戦略・SWOT・財務情報
    Genting Malaysia Berhad - Strategy, SWOT and Corporate Finance Report Summary Genting Malaysia Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Bancolombia S.A.:企業の戦略・SWOT・財務分析
    Bancolombia S.A. - Strategy, SWOT and Corporate Finance Report Summary Bancolombia S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆